Momelotinib, an aminopyrimidine derivative discovered by high-throughput enzyme and cell-based screening along with the optimization using structure-guided medicinal chemistry, is a potent and selective inhibitor of janus kinase 1 (JAK1), janus kinase 2 (JAK2) and tyrosine kinase 2 (TYK2).
This report contains market size and forecasts of Momelotinib in global, including the following market information:
Global Momelotinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Momelotinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Momelotinib companies in 2021 (%)
The global Momelotinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Momelotinib include Abcam, Adooq Bioscience, APExBIO Technology, BioVision, Cayman Chemical, Toronto Research Chemicals, Santa Cruz Biotechnology, Enzo Biochem and Taiclone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Momelotinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Momelotinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Momelotinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Momelotinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Momelotinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Momelotinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Momelotinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Momelotinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Momelotinib revenues share in global market, 2021 (%)
Key companies Momelotinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Momelotinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
Adooq Bioscience
APExBIO Technology
BioVision
Cayman Chemical
Toronto Research Chemicals
Santa Cruz Biotechnology
Enzo Biochem
Taiclone
Biorbyt
BOC Sciences
Aladdin